Prot# CPTK787AUS35//NU 05C4: A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas (NU Protocol #: NU 05C4)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/12/061/1/12

Funding

  • Novartis Pharmaceuticals Corporation (CPTK787AUS35)